Writing a literature review CL Winchester, M Salji Journal of Clinical Urology 9 (5), 308-312, 2016 | 333 | 2016 |
A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat CA Boucher, SK King, N Carey, R Krahe, CL Winchester, S Rahman, ... Human molecular genetics 4 (10), 1919-1925, 1995 | 234 | 1995 |
Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap J Pratt, C Winchester, N Dawson, B Morris Nature reviews Drug discovery 11 (7), 560-579, 2012 | 201 | 2012 |
Modelling prefrontal cortex deficits in schizophrenia: implications for treatment JA Pratt, C Winchester, A Egerton, SM Cochran, BJ Morris British journal of pharmacology 153 (S1), S465-S470, 2008 | 180 | 2008 |
Characterization of the Expression of DMPK and SIX5 in the Human Eye and Implications for Pathogenesis in Myotonic Dystrophy CL Winchester, RK Ferrier, A Sermoni, BJ Clark, KJ Johnson Human Molecular Genetics 8 (3), 481-492, 1999 | 109 | 1999 |
Converging evidence that sequence variations in the novel candidate gene MAP2K7 (MKK7) are functionally associated with schizophrenia CL Winchester, H Ohzeki, DA Vouyiouklis, R Thompson, JM Penninger, ... Human molecular genetics 21 (22), 4910-4921, 2012 | 58 | 2012 |
Altered functional brain network connectivity and glutamate system function in transgenic mice expressing truncated Disrupted-in-Schizophrenia 1 N Dawson, M Kurihara, DM Thomson, CL Winchester, A McVie, JR Hedde, ... Translational psychiatry 5 (5), e569-e569, 2015 | 47 | 2015 |
Functional analysis of the homeodomain protein SIX5 SE Harris, CL Winchester, KJ Johnson Nucleic acids research 28 (9), 1871-1878, 2000 | 42 | 2000 |
Structure, mapping and expression of the human gene encoding the homeodomain protein, SIX2 CA Boucher, CL Winchester, GM Hamilton, AD Winter, KJ Johnson, ... Gene 247 (1-2), 145-151, 2000 | 39 | 2000 |
Risk genes for schizophrenia: translational opportunities for drug discovery CL Winchester, JA Pratt, BJ Morris Pharmacology & therapeutics 143 (1), 34-50, 2014 | 35 | 2014 |
Expression of a homeobox gene (SIX5) in borderline ovarian tumours C Winchester, S Robertson, T MacLeod, K Johnson, M Thomas Journal of clinical pathology 53 (3), 212-217, 2000 | 28 | 2000 |
New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1) T Ashizawa, I Gonzales, N Ohsawa, RH Singer, M Devillers, ... Neurology 54 (6), 1218-1221, 2000 | 24 | 2000 |
Give every paper a read for reproducibility C Winchester Nature 557 (7706), 281-282, 2018 | 17 | 2018 |
Framing a research question: The first and most vital step in planning research E Anastasiadis, P Rajan, CL Winchester Journal of Clinical Urology 8 (6), 409-411, 2015 | 16 | 2015 |
Communicating your research (part 1)–to the scientific community C Udovicich, V Kasivisvanathan, CL Winchester Journal of Clinical Urology 10 (4), 396-399, 2017 | 11 | 2017 |
Is myotonic dystrophy a single-gene disorder? KJ Johnson, CA Boucher, SK King, CL Winchester, MES Bailey, ... Biochemical Society Transactions 24 (2), 510-513, 1996 | 8 | 1996 |
Gathering preliminary data CL Winchester, MJ Salji, V Kasivisvanathan Journal of Clinical Urology 10 (6), 568-572, 2017 | 7 | 2017 |
Disc1 mutation induced alterations in cerebral metabolism and in the response to acute subanaesthetic ketamine: a comparison of three different disc1 mutations N Dawson, C Winchester, A Mcvie, D Thomsom, Z Hughes, J Dunlop, ... SCHIZOPHRENIA RESEARCH 153, S192-S192, 2014 | 4 | 2014 |
Communicating your research (part 2): to the wider community C Udovicich, V Kasivisvanathan, CL Winchester Journal of Clinical Urology 11 (3), 208-214, 2018 | 3 | 2018 |
Non-clinical research–laboratory based M Salji, I Ahmad, CL Winchester Journal of Clinical Urology 9 (6), 362-364, 2016 | 1 | 2016 |